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As part of their symbiotic association with humans, intestinal bacteria sometimes need and
sometimes lend a helping hand. In this Select, we examine how commensal microorganisms or
the inflammation they produce cause undesirable outcomes, such as the development of type 2
diabetes or cancer. In addition, we see how commensal bacteria can receive assistance in coloni-
zation from resident phages and send messages to the host via outer membrane vesicles.Histology of IL-10 knockout mice intes-
tinesmonocolonizedwith E. coli contain-
ing and lacking pks. Photo courtesy of
Christian Jobin.Inflammation Fuels Genotoxic Gut Bacteria
Inflammation is a risk factor for colorectal cancer, but it has been unclear whether
manipulation of the host immune system by commensal microbiota plays a role in
the inflammation leading to colorectal cancer. To examine this further, Arthur et al.
(2012) colonized germ-free wild-type or colitis-susceptible interleukin-10 (IL-10)-
deficient animals with pathogen-free commensal organisms treated with and without
the colon-specific carcinogen azoxymethane (AOM). Mice lacking IL-10 develop
colitis, and the majority develop cancer; microbiome analysis showed that IL-10-
deficient mice have a reduced number of bacterial species. AOM treatment does
not seem to affect the microbiota, suggesting that this difference in richness is due
to changes in inflammation from IL-10 deficiency and not from cancer. In particular,
Proteobacteria populations expand in Il10 knockout mice with greater populations
of Enterobacteriaceae, of which Escherichia coli is a member. When gut microbiota
consists only of either E. coli or Enterococcus faecalis (another human commensal),
only mice colonized with E. coli develop invasive mucinous adenocarcinoma,
although both bacteria induce severe colitis, suggesting an E. coli-specific factor
may aid the development of colorectal cancer. Bioinformatic analysis of strains asso-
ciated with colitis and colorectal cancer suggested the importance of the polyketide
synthase (pks) pathogenicity island, which appears to induce DNA damage as
evidenced by the increased number of cells arrested at the G2/M checkpoint.
When treated with AOM and colonized with E. coli without pks, IL-10-deficient
mice show reduced tumor burden and decreased invasion without changes in inflam-
mation, suggesting pks may accelerate tumor formation. Host inflammation could
give genotoxic bacteria, such as pks-producing E. coli, the foothold they need to
expand within the gut. Although E. coli con-MGWAS identified gut microbial mar-
kers for classifying type 2 diabetes.
Image courtesy of Dongqian Shen and
Qiang Feng.taining pks is found in patients with intestinal inflammation and colorectal cancer, it
will be important to further explore the contribution of this pathogenicity island to colo-
rectal cancer development in humans.
Arthur, J.C., et al. (2012). Science 338, 120–123.
Microbial Prognosticators of Diabetes
Understanding the role of gut microbiota in dysbiosis is of considerable interest
because it could open avenues toward both preventive measures and treatments.
In a recent report, Qin et al. (2012) provide a thorough assessment of the gut micro-
biota associated with diabetes in a metagenome-wide association study (MGWAS)
of 345 fecal samples from diabetic Chinese patients and nondiabetic controls. Their
data extends previous studies with 16S ribosomal RNA and whole-genome shotgun
sequencing to determine the relative proportions of bacterial species in the gut of
diabetic patients and identify metagenomic linkage groups (MLGs) composed of
physically linked genetic material. Type 2 diabetes associates with 47 MLGs, and
17 of these MLGs could be assigned to known bacterial species. Opportunistic path-
ogens andmucin-degrading species are enriched in patients with type 2 diabetes, and
butyrate-producing organisms are enriched in controls. Microbes that are more prev-
alent in the context of type 2 diabetes are functionally enriched for membrane trans-
port, whereas the species more prevalent in controls are enriched in cell motility and
the metabolism of vitamins and cofactors. A type 2 diabetes index created using 50 of
these genemarkers accurately predicts type 2 diabetes in 33 individuals based on the
presence of these genes in their gut microbiota. Those with the highest index wereCell 151, November 21, 2012 ª2012 Elsevier Inc. 923
diabetic, and this index could be used more broadly to help predict who might be at risk for developing type 2 diabetes. This
work furthers the idea that particular types of gutmicrobes, such as butyrate-producing organisms,may be protective against
disease, whereas opportunistic pathogens, such as E. coli, could be associated with, or provide a helping hand, to chronic
diseases.
Qin, J., et al. (2012). Nature 490, 55–60.A Prophage Lends a Hand to Commensals
To thrive within the crowded confines of the human intestine, commensals must be
able to establish andmaintain a foothold. Duerkop et al. (2012) find that the production
of the composite phage 4V1/7 by Enterococcus faecalis, a commensal organism of
the human intestine, aids this strain in its competition with other E. faecalis strains
by lysing nearby competitors. Compared with strains lacking this phage, growth of
E. faecalis is enhanced by 4V1/7 production both in the gastrointestinal tract of
germ-free mice and in vitro. Free amino acids, which are found in millimolar concen-
trations in the intestine, may help induce 4V1/7 prophages in the intestine, given that
E. faecalis produces 4V1/7 in culture in response to amino acid availability. This work
furthers our understanding of the interplay between prophages and host biology, in
this case giving E. faecalis a helping hand during colonization, and provides a glimpse
of how E. faecalis can carve out a niche. Going forward, it will be important to identify
the specific trigger that induces 4V1/7 production in the intestine and to understand
whether4V1/7 plays a role in allowing other bacterial species to compete effectively in
the intestine.
Duerkop, B.A., et al. (2012). Proc. Natl. Acad. Sci. USA 109, 17621–17626.Transmission electron micrograph of
a 4V1/7 particle. Arrows indicate the
capsid and tail. Image courtesy of Breck
Duerkop and Sohini Mukherjee.
Electron micrograph of OMVs being
released from B. fragilis. Photo courtesy
of Yue Shen.Care Packages from Com-
mensals to Hosts
In addition to establishing a niche for them-
selves during colonization of the host gut,
commensal bacteria must suppress the
immune system to avoid clearance and elimi-
nation. A capsular polysaccharide (PSA) from
Bacteroides fragilis has previously been
shown to suppress intestinal immunity, per-
haps for the benefit of both the microbe and host, but the way in which PSAwas deliv-
ered to immune cells was unclear. Bacteria have several needle-like secretion
systems that require close contact between the bacterium and host cell, but they
can also release outer membrane vesicles (OMVs) from the bacterial membrane as
a kind of long-distance delivery system. Shen et al. (2012) show that PSA fromB. fragilis is packaged within OMVs and orally treating mice with OMVs protects against experimental colitis, an experimental
model for inflammatory bowel disease that is characterized by inflammation of the intestine. Furthermore, PSA in OMVs is
sensed by Toll-like receptor 2 (TLR-2) on dendritic cells, leading to tolerogenic dendritic cells and anti-inflammatory
responses. Growth arrest and DNA-damage-inducible protein (Gadd45a) is required for OMVs to induce expression of the
anti-inflammatory cytokine IL-10. In the context of experimental colitis, OMVs can restore colon length and reduce inflamma-
tion, so long as Gadd45a signaling is functional. This study leaves open the question of whether other anti-inflammatory roles
of PSA exist outside the gut—B. fragilis can prevent and treat experimental autoimmune encephalomyelitis, a model of
multiple sclerosis—or whether PSA could bemore broadly used in treating inflammation. Certainly, the unique delivery mech-
anism that helpsB. fragilismodulate its environment bears further examination aswe askwhat elsemight be sent expressmail
in the communication between commensals and their hosts.
Shen, Y., et al. (2012). Cell Host Microbe 12, 509–520.
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